Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
Kolben T, Müller L, Meister S, Keilmann L, Buschmann C, Trillsch F, Burges A, Czogalla B, Mitter S, Schmoeckel E, Corradini S, Mahner S, Jeschke U, Kessler M, Beyer S.
Kolben T, et al.
J Cancer Res Clin Oncol. 2022 Dec;148(12):3323-3335. doi: 10.1007/s00432-022-04098-8. Epub 2022 Jun 21.
J Cancer Res Clin Oncol. 2022.
PMID: 35729354
Free PMC article.
CONCLUSION: This is the first study examining the expression of SLeX, SLeA and LeY in EC, which can serve as additional future prognostic markers. ...The study was approved by the local ethics committee of the Ludwig-Maximilians University Munich (reference number 1 …
CONCLUSION: This is the first study examining the expression of SLeX, SLeA and LeY in EC, which can serve as additional future progno …